AFAP1-AS1 showed an increasing trend with the progression of PAAD tumor stage (stage I-IV) (Fig. 1 G).
← all excerpts
METTL3 promotes pancreatic cancer immune escape by m6A modification of lncRNA AFAP1-AS1 to enhance EGR2 stability.
2
—
—
The sentences
The expression and m6A modification levels of AFAP1-AS1 in PC tissues and cell lines were significantly higher than those of normal controls and showed a trend of increasing with tumor stage progression, and this expression pattern was closely associated with poor patient prognosis.